StockData
Imunon, Inc. logo

Imunon, Inc. (IMNN) shareholders

IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.61+0.02 (+3.06%)

Close on Nov 17, 2026Market cap $3.44MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
5.7%
0M of 6M shares
Institutional holders
23
6 new, 2 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 6 sales
Net sold $38.13K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Steven Boyd
Joint filing with Armistice Capital, LLC (9.99%)
450,3159.99%13G (passive) amendmentJun 30, 2026
Armistice Capital, LLC
Joint filing with Steven Boyd (9.99%)
349,9179.99%13G (passive)Dec 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of IMNNValueChange% of portfolio
Armistice Capital, LLC144,7672.58%$257.69K−203,5630.00%
Vanguard Capital Management LLC46,9670.84%$83.60K−1,0890.00%
Riverview Capital Advisers, LLC34,3640.61%$247.77K–0.07%
Geode Capital Management, LLC31,6290.56%$56.30K−1,5820.00%
Virtu Financial LLC17,4560.31%$31.00KNew0.00%
Vanguard Fiduciary Trust Co13,2690.24%$23.62K–0.00%
Northern Trust Corp10,3420.18%$18.41KNew0.00%
UBS Group AG5,2030.09%$9.26K+4,6280.00%
BlackRock, Inc.4,4640.08%$7.95K–0.00%
Tower Research Capital LLC (TRC)3,9520.07%$7.04K+2,0860.00%
Wells Fargo & Company/Mn3,3420.06%$5.95K–0.00%
Morgan Stanley1,5740.03%$2.80K−1,4610.00%
SBI Securities Co., Ltd.1,0270.02%$1.83K–0.00%
Barclays PLC1940.00%$345New0.00%
JPMorgan Chase & Co1340.00%$241New0.00%
Caitong International Asset Management Co., Ltd80.00%$14New0.00%
Group One Trading, L.P.60.00%$11–0.00%
Northwestern Mutual Wealth Management Co30.00%$5New0.00%
Osaic Holdings, Inc.20.00%$3–0.00%
Steigerwald, Gordon & Koch Inc.10.00%$2–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026230M5.7%6 / 24 / 20M0M
Q1 2026191M9.0%3 / 63 / 30M0M
Q4 2025200M7.7%3 / 46 / 00M0M
Q3 2025170M2.8%16 / 10 / 00M0M
Q2 202510M0.0%1 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

5 funds held IMNN in Q2 2026, 63% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of IMNNValue% of fundAs of
Vanguard Extended Market Index Fund46,9670.84%$83.60K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund20,4130.36%$44.50K0.00%May 31, 2026
Fidelity Series Total Market Index Fund4,7440.08%$10.34K0.00%May 31, 2026
Fidelity Total Market Index Fund1,7760.03%$3.87K0.00%May 31, 2026
Fidelity Nasdaq Composite Index Fund1630.00%$3550.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Stacy LindborgPresident and CEO, Director123,3592.20%Nov 10, 2026
Michael H. TardugnoExecutive Chairman of Board, Director133,1332.37%Nov 10, 2026
Douglas Vincent FallerChief Medical Officer76,3561.36%Nov 10, 2026
Susan EylwardGeneral Counsel and Corp Sec2,8960.05%Sep 1, 2026
Joshua BlacherCFO––Jul 7, 2026
Jeffrey Wayne ChurchCFO260.00%Jan 20, 2026
Kimberly BraggCFO20,4000.36%Jan 6, 2026
Khursheed AnwerChief Scientific Officer5,0000.09%Jan 6, 2026
Christine A. PellizzariDirector28,6650.51%Nov 10, 2026
Frederick J. FritzDirector46,2920.82%Nov 10, 2026
James E. DentzerDirector34,1970.61%Nov 10, 2026
Donald P. BraunDirector33,6430.60%Nov 10, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Donald P. Braun
Director
Nov 6, 2026Award+11,746$0.84$9.93K33,643
James E. Dentzer
Director
Nov 6, 2026Award+13,166$0.84$11.13K34,197
Frederick J. Fritz
Director
Nov 6, 2026Award+13.166$0.84$1128,242
Christine A. Pellizzari
Director
Nov 6, 2026Award+13,166$0.84$11.13K28,665
Douglas Vincent Faller
Chief Medical Officer
Nov 6, 2026Award+1,596$0.84$1.35K76,356
Stacy Lindborg
President and CEO, Director
Nov 6, 2026Award+3,804$0.84$3.21K122,581
Michael H. Tardugno
Executive Chairman of Board, Director
Nov 6, 2026Award+9,969$0.84$8.42K128,511
Michael H. Tardugno
Executive Chairman of Board, Director
Oct 23, 2026Award+6,821$1.24$8.42K118,542
Stacy Lindborg
President and CEO, Director
Oct 23, 2026Award+2,603$1.24$3.21K118,777
Douglas Vincent Faller
Chief Medical Officer
Oct 23, 2026Award+1,092$1.24$1.35K48,019
Douglas Vincent Faller
Chief Medical Officer
Oct 23, 2026Award+26,741$1.24$33.03K74,760
Michael H. Tardugno
Executive Chairman of Board, Director
Oct 9, 2026Award+7,800$1.08$8.42K111,721
Stacy Lindborg
President and CEO, Director
Oct 9, 2026Award+2,977$1.08$3.22K116,174
Douglas Vincent Faller
Chief Medical Officer
Oct 9, 2026Award+1,249$1.08$1.35K46,927
Stacy Lindborg
President and CEO, Director
Sep 25, 2026Award+6,697$1.41$9.44K113,197
Douglas Vincent Faller
Chief Medical Officer
Sep 25, 2026Award+4,390$1.41$6.19K45,678
Michael H. Tardugno
Executive Chairman of Board, Director
Sep 25, 2026Award+7,169$1.41$10.11K103,921
Stacy Lindborg
President and CEO, Director
Sep 11, 2026Award+5,504$1.47$8.09K105,580
Michael H. Tardugno
Executive Chairman of Board, Director
Sep 11, 2026Award+5,824$1.47$8.56K95,699
Douglas Vincent Faller
Chief Medical Officer
Sep 11, 2026Award+4,211$1.47$6.19K41,288
Susan Eylward
General Counsel and Corp Sec
Aug 31, 2026Sale−2,525$1.56$3.94K2,896
Susan Eylward
General Counsel and Corp Sec
Aug 28, 2026Award+2,525$1.60$4.04K5,421
Michael H. Tardugno
Executive Chairman of Board, Director
Aug 28, 2026Award+7,371$1.60$11.79K89,875
Stacy Lindborg
President and CEO, Director
Aug 28, 2026Award+6,822$1.60$10.92K100,076
Douglas Vincent Faller
Chief Medical Officer
Aug 28, 2026Award+3,626$1.60$5.80K37,077
Susan Eylward
General Counsel and Corp Sec
Aug 17, 2026Sale−2,449$1.63$3.99K2,896
Michael H. Tardugno
Executive Chairman of Board, Director
Aug 14, 2026Award+7,147$1.65$11.79K82,504
Susan Eylward
General Counsel and Corp Sec
Aug 14, 2026Award+2,449$1.65$4.04K5,345
Stacy Lindborg
President and CEO, Director
Aug 14, 2026Award+6,615$1.65$10.91K93,254
Douglas Vincent Faller
Chief Medical Officer
Aug 14, 2026Award+3,516$1.65$5.80K33,451
Susan Eylward
General Counsel and Corp Sec
Aug 3, 2026Sale−2,541$1.57$3.99K2,896
Christine A. Pellizzari
Director
Jul 31, 2026Award+6,934$1.59$11.03K15,076
Stacy Lindborg
President and CEO, Director
Jul 31, 2026Award+5,010$1.59$7.97K86,639
Donald P. Braun
Director
Jul 31, 2026Award+6,180$1.59$9.83K15,499
Frederick J. Fritz
Director
Jul 31, 2026Award+6,934$1.59$11.03K21,031
Susan Eylward
General Counsel and Corp Sec
Jul 31, 2026Award+2,541$1.59$4.04K5,437
James E. Dentzer
Director
Jul 31, 2026Award+6,934$1.59$11.03K21,897
Douglas Vincent Faller
Chief Medical Officer
Jul 31, 2026Award+3,649$1.59$5.80K29,935
Michael H. Tardugno
Executive Chairman of Board, Director
Jul 31, 2026Award+6,358$1.59$10.11K75,357
Susan Eylward
General Counsel and Corp Sec
Jul 20, 2026Sale−2,150$1.78$3.83K2,896
Stacy Lindborg
President and CEO, Director
Jul 17, 2026Award+4,907$1.83$8.98K81,629
Michael H. Tardugno
Executive Chairman of Board, Director
Jul 17, 2026Award+4,603$1.83$8.42K68,999
Douglas Vincent Faller
Chief Medical Officer
Jul 17, 2026Award+3,082$1.83$5.64K26,286
Susan Eylward
General Counsel and Corp Sec
Jul 17, 2026Award+2,150$1.83$3.93K5,046
Susan Eylward
General Counsel and Corp Sec
Jul 6, 2026Sale−920$1.88$1.73K2,896
Susan Eylward
General Counsel and Corp Sec
Jul 2, 2026Award+920$1.91$1.76K3,816
Stacy Lindborg
President and CEO, Director
Jul 2, 2026Award+2,534$1.91$4.84K76,722
Michael H. Tardugno
Executive Chairman of Board, Director
Jul 2, 2026Award+4,410$1.91$8.42K64,396
Douglas Vincent Faller
Chief Medical Officer
Jul 2, 2026Award+1,308$1.91$2.50K23,204
Susan Eylward
General Counsel and Corp Sec
Jun 29, 2026Sale−11,800$1.75$20.65K2,896
Douglas Vincent Faller
Chief Medical Officer
Jun 25, 2026Award+21,896$1.72$37.66K21,896
Stacy Lindborg
President and CEO, Director
Jun 25, 2026Award+67,150$1.72$115.50K74,188
Susan Eylward
General Counsel and Corp Sec
Jun 25, 2026Award+14,696$1.72$25.28K14,696
Michael H. Tardugno
Executive Chairman of Board, Director
Jun 25, 2026Award+42,519$1.72$73.13K59,986
Michael H. Tardugno
Executive Chairman of Board, Director
Jun 18, 2026Award+4,629$1.82$8.42K17,467
Stacy Lindborg
President and CEO, Director
Jun 18, 2026Award+1,803$1.82$3.28K7,038
Michael H. Tardugno
Executive Chairman of Board, Director
Jun 5, 2026Award+4,089$2.06$8.42K12,838
Stacy Lindborg
President and CEO, Director
Jun 5, 2026Award+1,593$2.06$3.28K5,235
Frederick J. Fritz
Director
May 22, 2026Award+10,330$2.20$22.73K14,097
Donald P. Braun
Director
May 22, 2026Award+5,011$2.20$11.02K9,319

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
4.21%
0M shares short
Days to cover
1.5
At 0M shares a day
Change since last report
+245.8%
From 0M shares
Short volume, 20 days
55.4%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Imunon's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,937 shares on Aug 20, 2026 over the last 90 days.

Congress trades

4 trades in Imunon reported by 1 member of the House

MemberTypeTradedAmountFiled
Roger W. Marshall
KS01 · child
SoldJun 16, 2017$1K–15KAug 6, 2018
416 days late
Roger W. Marshall
KS01 · child
BoughtJun 16, 2017$1K–15KAug 6, 2018
416 days late
Roger W. Marshall
KS01 · child
SoldJun 5, 2017$1K–15KAug 6, 2018
427 days late
Roger W. Marshall
KS01 · child
BoughtJun 5, 2017$1K–15KAug 6, 2018
427 days late

See a number that looks wrong?